Fulton Breakefield Broenniman’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-30,713
Closed -$2.67M 130
2015
Q1
$2.67M Buy
30,713
+2,397
+8% +$201K 0.59% 64
2014
Q4
$2.4M Buy
28,316
+1,085
+4% +$84.8K 0.53% 68
2014
Q3
$1.92M Buy
27,231
+1,850
+7% +$132K 0.45% 75
2014
Q2
$1.76M Buy
25,381
+2,732
+12% +$192K 0.43% 77
2014
Q1
$1.7M Buy
22,649
+559
+3% +$41.9K 0.44% 74
2013
Q4
$1.55M Sell
22,090
-1,107
-5% -$72.3K 0.41% 78
2013
Q3
$1.43M Buy
23,197
+2,370
+11% +$153K 0.39% 82
2013
Q2
$1.28M Buy
+20,827
New +$1.25M 0.38% 82

Other funds holding ESRX

Fulton Breakefield Broenniman's ESRX Position: Q2 2015 in Review

Fulton Breakefield Broenniman sold out of Express Scripts Holding Company (ESRX) in Q2 2015, closing a stake of 30,713 shares — an estimated $2.67M sold.

Fulton Breakefield Broenniman first reported a position in ESRX in Q2 2013 and held it in 8 quarters. The position peaked at $2.67M in Q1 2015. 1,253 funds tracked by Wall St. Rank hold ESRX as of Q2 2015.

  • Fulton Breakefield Broenniman reported no remaining Express Scripts Holding Company position as of Q2 2015 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 30,713 Express Scripts Holding Company shares in Q2 2015, an estimated $2.67M.
  • Fulton Breakefield Broenniman first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 8 quarters.
  • Fulton Breakefield Broenniman's Express Scripts Holding Company position peaked at $2.67M in Q1 2015.
  • 1,253 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2015.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2015, filed 4 Aug 2015.